269 related articles for article (PubMed ID: 30712866)
1. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.
Georgouli M; Herraiz C; Crosas-Molist E; Fanshawe B; Maiques O; Perdrix A; Pandya P; Rodriguez-Hernandez I; Ilieva KM; Cantelli G; Karagiannis P; Mele S; Lam H; Josephs DH; Matias-Guiu X; Marti RM; Nestle FO; Orgaz JL; Malanchi I; Fruhwirth GO; Karagiannis SN; Sanz-Moreno V
Cell; 2019 Feb; 176(4):757-774.e23. PubMed ID: 30712866
[TBL] [Abstract][Full Text] [Related]
2. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Samain R; Maiques O; Monger J; Lam H; Candido J; George S; Ferrari N; KohIhammer L; Lunetto S; Varela A; Orgaz JL; Vilardell F; Olsina JJ; Matias-Guiu X; Sarker D; Biddle A; Balkwill FR; Eyles J; Wilkinson RW; Kocher HM; Calvo F; Wells CM; Sanz-Moreno V
Sci Adv; 2023 Oct; 9(42):eadi0244. PubMed ID: 37851808
[TBL] [Abstract][Full Text] [Related]
3. Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.
Orgaz JL; Crosas-Molist E; Sadok A; Perdrix-Rosell A; Maiques O; Rodriguez-Hernandez I; Monger J; Mele S; Georgouli M; Bridgeman V; Karagiannis P; Lee R; Pandya P; Boehme L; Wallberg F; Tape C; Karagiannis SN; Malanchi I; Sanz-Moreno V
Cancer Cell; 2020 Jan; 37(1):85-103.e9. PubMed ID: 31935375
[TBL] [Abstract][Full Text] [Related]
4. Myosin II in Cancer Cells Shapes the Immune Microenvironment.
Arabzadeh A; Quail DF
Trends Mol Med; 2019 Apr; 25(4):257-259. PubMed ID: 30871808
[TBL] [Abstract][Full Text] [Related]
5. AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.
Crosas-Molist E; Graziani V; Maiques O; Pandya P; Monger J; Samain R; George SL; Malik S; Salise J; Morales V; Le Guennec A; Atkinson RA; Marti RM; Matias-Guiu X; Charras G; Conte MR; Elosegui-Artola A; Holt M; Sanz-Moreno V
Nat Commun; 2023 May; 14(1):2740. PubMed ID: 37217519
[TBL] [Abstract][Full Text] [Related]
6. WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.
Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V
Nat Commun; 2020 Oct; 11(1):5315. PubMed ID: 33082334
[TBL] [Abstract][Full Text] [Related]
7. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination.
Cantelli G; Orgaz JL; Rodriguez-Hernandez I; Karagiannis P; Maiques O; Matias-Guiu X; Nestle FO; Marti RM; Karagiannis SN; Sanz-Moreno V
Curr Biol; 2015 Nov; 25(22):2899-914. PubMed ID: 26526369
[TBL] [Abstract][Full Text] [Related]
9. Location, location, location: Melanoma cells "living at the edge".
Maiques O; Sanz-Moreno V
Exp Dermatol; 2022 Jan; 31(1):82-88. PubMed ID: 34185923
[TBL] [Abstract][Full Text] [Related]
10. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
11. Diverse matrix metalloproteinase functions regulate cancer amoeboid migration.
Orgaz JL; Pandya P; Dalmeida R; Karagiannis P; Sanchez-Laorden B; Viros A; Albrengues J; Nestle FO; Ridley AJ; Gaggioli C; Marais R; Karagiannis SN; Sanz-Moreno V
Nat Commun; 2014 Jun; 5():4255. PubMed ID: 24963846
[TBL] [Abstract][Full Text] [Related]
12. The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages.
Li C; Xue VW; Wang QM; Lian GY; Huang XR; Lee TL; To KF; Tang PM; Lan HY
Cancer Immunol Res; 2020 Aug; 8(8):1004-1017. PubMed ID: 32532809
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
[TBL] [Abstract][Full Text] [Related]
14. SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II.
Choi DS; Stark DJ; Raphael RM; Wen J; Su J; Zhou X; Chang CC; Zu Y
Int J Cancer; 2015 Mar; 136(5):E219-29. PubMed ID: 25137150
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma.
Shinada M; Kato D; Motegi T; Tsuboi M; Ikeda N; Aoki S; Iguchi T; Li T; Kodera Y; Ota R; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Kato Y; Nishimura R; Nakagawa T
Mol Cancer Res; 2023 Nov; 21(11):1205-1219. PubMed ID: 37493578
[TBL] [Abstract][Full Text] [Related]
16. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
17. TAp73 represses NF-κB-mediated recruitment of tumor-associated macrophages in breast cancer.
Wolfsberger J; Sakil HAM; Zhou L; van Bree N; Baldisseri E; de Souza Ferreira S; Zubillaga V; Stantic M; Fritz N; Hartman J; Rolny C; Wilhelm MT
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649219
[TBL] [Abstract][Full Text] [Related]
18. Myosin II in mechanotransduction: master and commander of cell migration, morphogenesis, and cancer.
Aguilar-Cuenca R; Juanes-García A; Vicente-Manzanares M
Cell Mol Life Sci; 2014 Feb; 71(3):479-92. PubMed ID: 23934154
[TBL] [Abstract][Full Text] [Related]
19. Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C.
Grahovac J; Becker D; Wells A
J Invest Dermatol; 2013 Jan; 133(1):210-20. PubMed ID: 22951722
[TBL] [Abstract][Full Text] [Related]
20. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
